ホームPRGO • NYSE
add
ペリゴ
前日の終値
$24.38
日次変動幅
$24.27 - $24.35
年間変動幅
$23.89 - $33.96
時価総額
33.15億 USD
平均取引高
130.24万
株価収益率
-
配当利回り
4.55%
優先市場
NYSE
財務情報
損益計算書
収益
純利益
(USD) | 2024年9月info | 前年比変化率 |
---|---|---|
収益 | 10.88億 | -3.23% |
営業費用 | 2.91億 | -12.72% |
純利益 | -2100.00万 | -247.89% |
純利益率 | -1.93 | -253.17% |
1 株当たりの収益 | 0.81 | 26.56% |
EBITDA | 1.96億 | 15.93% |
実効税率 | 180.73% | — |
貸借対照表
総資産
負債総額
(USD) | 2024年9月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 14.62億 | 144.39% |
総資産 | 112.03億 | 4.14% |
負債総額 | 66.37億 | 10.25% |
純資産 | 45.66億 | — |
発行済み株式 | 1.36億 | — |
帳簿価格 | 0.73 | — |
総資産利益率 | 2.63% | — |
資本利益率 | 3.09% | — |
キャッシュ フロー
現金の純増減額
(USD) | 2024年9月info | 前年比変化率 |
---|---|---|
純利益 | -2100.00万 | -247.89% |
営業キャッシュ フロー | 4220.00万 | -66.10% |
投資キャッシュ フロー | 2.13億 | 792.83% |
財務キャッシュ フロー | 6.53億 | 1,608.78% |
現金の純増減額 | 9.21億 | 2,036.19% |
フリー キャッシュ フロー | 2.20億 | 174.19% |
概要
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
CEO
設立
1887
ウェブサイト
従業員数
9,140